- 1999 Biocause tablets and capsules facility received GMP certificate.
- 1996-2000 Winner of Excellence for Drug Quality Awards from Hubei State Drug Administration.
- 2000 Biocause large volume parenteral facility received GMP certificate.
- 2001 Biocause small volume parenteral facility received GMP certificate.
- 2003 bulk API manufacturing facility received SDAGMP certificate.
- 2003 Received Certificate of Suitability (COS) from EDQM for bulk Ibuprofen Drug Substance.
*US DMF (#15839) filed and referenced to FDA in 2002.
|
 |
|
| |
|
|
|
